Both in Pharmaceuticals
OnKure Therapeutics vs Organogenesis Holdings
Over the past year OKUR returned −21.0% and ORGO returned −80.3%; their daily moves had a correlation of 0.05.
OKUR −21.0% ORGO −80.3%Growth of $1, one year, split-adjusted
| Metric | OKUR | ORGO |
|---|---|---|
| Price | $2.63 | $0.8247 |
| Market cap | $106.5M | $106.1M |
| Today | +1.35% | −8.61% |
| 1 month | +1.2% | −40.5% |
| 6 months | −48.4% | −64.1% |
| Year to date | −9.3% | −84.1% |
| 1 year | −26.3% | −80.7% |
| Revenue growth (YoY) | — | −56.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −227.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.2× |
| Net cash | $176.4M | $34.4M |
| Dividend yield | — | — |
| Volatility (60d) | 55.5% | 74.5% |
| Short % of float | 5.6% | 21.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).